Pulmonx EBITDA 2019-2024 | LUNG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pulmonx ebitda from 2019 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pulmonx ebitda from 2019 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$37.7B
Tempus AI (TEM)	$8B
Hims & Hers Health (HIMS)	$7B
Inspire Medical Systems (INSP)	$5.7B
IRhythm Technologies (IRTC)	$3.5B
Privia Health (PRVA)	$2.7B
Enovis (ENOV)	$2.7B
Azenta (AZTA)	$2.4B
Clover Health Investments (CLOV)	$2.2B
Omnicell (OMCL)	$2.1B
Schrodinger (SDGR)	$1.8B
10x Genomics (TXG)	$1.8B
Phreesia (PHR)	$1.7B
Butterfly Network (BFLY)	$748M
Standard BioTools (LAB)	$588M
Talkspace (TALK)	$537M
Fulgent Genetics (FLGT)	$515M
TruBridge (TBRG)	$362M
Nyxoah SA (NYXH)	$354M
Health Catalyst (HCAT)	$343M
SOPHiA GENETICS SA (SOPH)	$235M
American Well (AMWL)	$169M
EUDA Health Holdings (EUDA)	$96M
P3 Health Partners (PIII)	$69M
CareCloud (CCLD)	$58M
HeartBeam (BEAT)	$58M
111 (YI)	$47M
Outset Medical (OM)	$44M
Zepp Health (ZEPP)	$42M
SHL Telemedicine (SHLT)	$42M